The New York Stock Exchange helped ring in this year’s Fierce 15 by honoring the winners on the trading floor Monday morning.

Angelini Pharma has worked out a $550 million-plus biobucks deal to get its hands on a Korean biotech’s preclinical neuro ...

As the financial ramifications of federal research cuts come into focus, several organizations are warning of the looming ...

Japan biotech xFOREST Therapeutics is teaming up with a drug discovery solutions provider in a research pact aiming to ...

Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ...

Nina Schor, M.D., Ph.D., will officially stop serving as head of the NIH’s Office of Intramural Research (OIR) on Sept. 30, ...

Intuitive has begun rolling out real-time surgical metrics to the operator consoles of its da Vinci 5 robot, in what it ...

The healthcare world is awash in data—medical device data, electronic patient records, public-health surveillance data, clinical data, wearable data, and more. | Five Key Data Management Questions for ...

Worldwide Clinical Trials is looking to grow to global CRO dominance with a new leader at the helm. | Worldwide Clinical ...

Momentum started building behind icotrokinra last year when J&J posted results from another phase 3 trial, dubbed Iconic-Lead, which saw 64.7% of treated patients achieve clear or almost clear skin at ...

Precision medicine is reshaping the landscape of clinical development, offering more advanced strategies to align therapies with individual biological variability. Recent research shows that drug ...

Medical device manufacturer Exactech has agreed to pay $8 million to settle allegations that it concealed defects in a popular line of artificial knee implants, which have been blamed for thousands | ...